Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 17Myelodysplastic Syndromes 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Biphenotypic, Acute 10Leukemia, Myelomonocytic, Chronic 9Hematologic Neoplasms 8Hodgkin Disease 6Myeloproliferative Disorders 5Lymphoma, Non-Hodgkin 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Lymphoma, T-Cell 3Lymphoma, Follicular 3Leukemia, Lymphocytic, Chronic, B-Cell 3Graft vs Host Disease 3Burkitt Lymphoma 3Anemia, Refractory, with Excess of Blasts 3Primary Myelofibrosis 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Prolymphocytic 2Leukemia, Myeloid 2Leukemia, Monocytic, Acute 2Leukemia, Lymphoid 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Thrombocythemia, Essential 1Sarcoma, Ewing 1Rhabdomyosarcoma 1

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Non-Malignant Neoplasm × Whole-Body Irradiation × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡